| An EQ-5D-5L value set for Italy using videoconferencing interviews and feasibility of a new mode of administration AP Finch, M Meregaglia, O Ciani, B Roudijk, C Jommi Social Science & Medicine 292, 114519, 2022 | 63 | 2022 |
| Cultural values: can they explain differences in health utilities between countries? B Roudijk, ART Donders, PFM Stalmeier Medical Decision Making 39 (5), 605-616, 2019 | 56 | 2019 |
| Value sets for EQ-5D-5L: a compendium, comparative review & user guide N Devlin, B Roudijk, K Ludwig Springer Nature, 2022 | 52 | 2022 |
| Cultural values: can they explain self-reported health? B Roudijk, R Donders, P Stalmeier Quality of Life Research 26, 1531-1539, 2017 | 36 | 2017 |
| The EQ-5D-5L valuation study in Egypt S Al Shabasy, M Abbassi, A Finch, B Roudijk, D Baines, S Farid Pharmacoeconomics 40 (4), 433-447, 2022 | 28 | 2022 |
| Setting dead at zero: applying scale properties to the QALY model B Roudijk, ART Donders, PFM Stalmeier Medical Decision Making 38 (6), 627-634, 2018 | 25 | 2018 |
| Valuation of the EQ-5D-3L in Russia V Omelyanovskiy, N Musina, S Ratushnyak, T Bezdenezhnykh, ... Quality of Life Research 30, 1997-2007, 2021 | 24 | 2021 |
| Developing the EQ-5D-5L value set for Uganda using the ‘lite’protocol F Yang, KR Katumba, B Roudijk, Z Yang, P Revill, S Griffin, PN Ochanda, ... Pharmacoeconomics, 1-13, 2022 | 23 | 2022 |
| A value set for the EQ-5D-Y-3L in the Netherlands B Roudijk, A Sajjad, B Essers, S Lipman, P Stalmeier, AP Finch Pharmacoeconomics 40 (Suppl 2), 193-203, 2022 | 21 | 2022 |
| Estimating an EQ-5D-Y-3L value set for indonesia by mapping the DCE onto TTO values TS Fitriana, B Roudijk, FD Purba, JJV Busschbach, E Stolk PharmacoEconomics 40 (Suppl 2), 157-167, 2022 | 11 | 2022 |
| An EQ-5D-Y-3L value set for Belgium S Dewilde, B Roudijk, NH Tollenaar, JM Ramos-Goñi Pharmacoeconomics 40 (Suppl 2), 169-180, 2022 | 11 | 2022 |
| In a child’s shoes: composite time trade-off valuations for EQ-5D-Y-3L with different proxy perspectives SA Lipman, BAB Essers, AP Finch, A Sajjad, PFM Stalmeier, B Roudijk Pharmacoeconomics 40 (Suppl 2), 181-192, 2022 | 11 | 2022 |
| The sensitivity and specificity of repeated and dominant choice tasks in discrete choice experiments MF Jonker, B Roudijk, M Maas Value in Health 25 (8), 1381-1389, 2022 | 11 | 2022 |
| Valuing health-related quality of life using a hybrid approach: Tunisian value set for the EQ-5D-3L J Chemli, C Drira, H Felfel, B Roudijk, F Al Sayah, M Kouki, A Kooli, ... Quality of Life Research 30, 1445-1455, 2021 | 11 | 2021 |
| Modifying the composite time trade-off method to improve its discriminatory power M Jakubczyk, SA Lipman, B Roudijk, R Norman, E Pullenayegum, Y Yang, ... Value in Health 26 (2), 280-291, 2023 | 7 | 2023 |
| EQ-5D-Y-3L Value Sets, Valuation Methods and Conceptual Questions N Devlin, B Roudijk, R Viney, E Stolk PharmacoEconomics 40 (Suppl 2), 123-127, 2022 | 7 | 2022 |
| EQ-5D-5L value set summaries B Roudijk, K Ludwig, N Devlin Value Sets for EQ-5D-5L: A Compendium, Comparative Review & User Guide, 55-212, 2022 | 7 | 2022 |
| A threshold explanation for the lack of variation in negative composite time trade-off values B Roudijk, R Donders, P Stalmeier Quality of Life Research 31 (9), 2753-2761, 2022 | 6 | 2022 |
| A head-on ordinal comparison of the composite time trade-off and the better-than-dead method B Roudijk, ART Donders, PFM Stalmeier Value in Health 23 (2), 236-241, 2020 | 5 | 2020 |
| How Do EQ-5D-5L Value Sets Differ? B Roudijk, B Janssen, JA Olsen Value Sets for EQ-5D-5L: A Compendium, Comparative Review & User Guide, 235-258, 2022 | 4 | 2022 |
